DEVELOPMENT AND VALIDATION OF RATIO SPECTRA DERIVATIVE METHOD FOR THE SIMULTANEOUS ESTIMATION OF BETAHISTINE DIHYDROCHLORIDE AND PROCHLORPERAZINE MALEATE IN TABLET DOSAGE FORM

Authors

  • PATEL VISHVAS D Department of Quality Assurance, S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Ganpat Vidyanagar, Mehsana, Gujarat, India.
  • PATEL PARESH U Department of Quality Assurance, S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Ganpat Vidyanagar, Mehsana, Gujarat, India

Keywords:

Betahistine Dihydrochloride Prochlorperazine Maleate , Ratio spectra derivative, Tablet dosage form.

Abstract

The Ratio spectra derivative spectrophotometric method was developed for the simultaneous determination of Betahistine Dihydrochloride (BET) and Prochlorperazine Maleate (PRO) in tablet dosage form. In this method ratio spectra of one drug is taken then they divided by one of the standard concentration of another drug and then converted into first derivative method. The first derivative amplitudes at 216 and 272.40 nm were selected for the determination of PRO and BET respectively. The wavelength interval (Dl) was selected as 8 nm. 0.1 N HCL was used as the solvent. BET shows linearity in range of 4-24?g/ml concentration while PRO shows linearity range 3-18?g/ml concentration. The method was validated statistically and recovery studies were carried out. It was found to be accurate, precise and reproducible. The method was applied to the assay of the drugs in tablet dosage form, which were found in the range of 98.98% and 98.73% of the labeled value for both Betahistine Dihydrochloride and Prochlorperazine maleate. Hence, the method here in described can be suitable for analysis of BET and PRO in quality control of combined pharmaceutical dosage forms.

Downloads

Download data is not yet available.

References

Maryadele J O’ Neil ed, Merck Index, 14th Edition, Merck & Co. Inc, White House Station NJ: 2005.1177.

U. S. Pharmacopoeia/ NF Vol. II. The United states pharmacopeial convention, Twinbrook pathway Rockvillae, 2013.2635.

Indian Pharmacopoeia. Vol. II. The Controller of Publication. 6th edition. Govt. of India. New Delhi, 2010.897-898.

British Pharmacopoeia. Vol. I. Stationary office. London Medicines and Healthcare product regulatory agency, 2010. 254-255.

European Pharmacopoeia 6.0. Vol. II. 6th edition. Starboary: Council of Europe, 2008.1292.

Ensafi A., Doozandeh F., AllafchianA.,Potentiometric Sensor for Betahistine Determination in Pharmaceuticals, Urine and Blood Serum, J. Braz. Chem. Soc., 2010;21(12):2446-2453.

Kumar A., ChomwalR.,Nanda S., Spectrophotometric estimation of Betahistine hydrochloride in tablet formulations, J Pharm Bio all Sci 2010;2:121-123.

Khedr A., Mahmoud S., Stress degradation studies on Betahistine and development of a validated stability-indicating assay method, Journal of Chromatography B, 2008; 869: 111–117.

Jain R., Yadav R., Voltammetric assay of anti-vertigo drug Betahistine hydrochloride in sodium lauryl sulphate, Colloids and Surfaces A: Physicochem. Eng. Aspects 2010; 366; 63–67.

Indian Pharmacopoeia. Vol. II. The Controller of Publication. 6th edition. Govt. of India. New Delhi, 2010.1972.

Japanese Pharmacopoeia. 15th edition, Shibuya Tokyo Japan; Society of Japanese Pharmacopeia; 2006.1033.

U. S. Pharmacopoeia/ NF Vol. II. The United states pharmacopeial convention, Twinbrook pathway Rockvillae, 2013.4912.

British Pharmacopoeia. Vol. II. Stationary office. London Medicines and Healthcare product regulatory agency, 2010.1769.

European Pharmacopoeia 6.0. Vol. II. 6th edition. Starboary: Council of Europe, 2008.2756.

Aman T., Majeed Z., Kazi A., KhanI., Spectrophometric determination of Prochlorperazine Maleate in Pure and pharmaceutical preparation, MikrochimicaActa, 2002;138: 13-17.

Venkatesh D., Sundaram S., Meyyanathan S.,Muralidharan S., Shanmugam R., Kannan E., Bhojraj S., and Santhi S., Bioavailability Studies on Developed Prochlorperazine Maleate Sustained Release Tablets by HPLC, Journal of Bioanalysis& Biomedicine, 2009;1: 54-59.

Bhagwat G. B., Wate S. P. and Mundhey A. S., Development and Validation of UV Spectrophotometric Method for Estimation of Prochlorperazine Maleate and Pyridoxine Hydrochloride in Tablet Dosage Form by UV Using Multi-Component Mode of Analysis,2013; 3:20-25.

Bhosale D., Nikalje A., Development and validation of RP-chromatography for simultaneous determination of paracetamol, caffeine, ergotamine and Prochlorperazine in tablets, Asian Journal of Pharmaceutical Sciences,2013; 7 (5): 364-370.

ICH, Q2(R1) Validation of Analytical Procedure:Text and Methodology, International Conference on Harmonization, IFPMA, Geneva, Switzerland.[Cited 2013 Feb 5], Available from:www.ich.org/fileadmin/Public.../ICH.../Q2_R1__Guideline.pdf

Published

2014-03-14
Statistics
57 Views | 34 Downloads
Citatons

How to Cite

PATEL VISHVAS D, and PATEL PARESH U. “DEVELOPMENT AND VALIDATION OF RATIO SPECTRA DERIVATIVE METHOD FOR THE SIMULTANEOUS ESTIMATION OF BETAHISTINE DIHYDROCHLORIDE AND PROCHLORPERAZINE MALEATE IN TABLET DOSAGE FORM”. International Journal of Pharmaceutics and Drug Analysis, vol. 2, no. 3, Mar. 2014, pp. 155-60, https://ijpda.com/index.php/journal/article/view/26.

Issue

Section

Research Articles
Share |